Main Menu

Preclinical Modelling of Paediatric Cancer Evolution Group

Dr Alejandra Bruna's group is studying the phenotypic changes occurring through treatment to explore modulation of transcription dynamics as a therapeutic strategy in aggressive solid paediatric cancers.

Group leader

Dr Alejandra Bruna

Dr Alejandra Bruna

Dr Alejandra Bruna leads the Preclinical Modelling of Paediatric Cancer Evolution Group. She has experience leading and contributing to preclinical programmes using improved patient-derived tumour models.

ORCID 0000-0003-1214-9665

Group members

Alejandro Allo Anido

ITN Marie Curie Research Fellow

Emilia Chen

PhD Student

Dr Christie English

Senior Scientific Officer +44 20 3437 6861

Sian Hamer

PhD Student +44 20 3437 6297

Dr Cecilia Roux

Post-doctoral Fellow

Dr Ayeh Sadr

Postdoctoral Training Fellow +44 20 3437 3514

Abigail Shea

Postdoctoral Training Fellow +44 20 3437 6827